e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relations between the sinonasal development and the lung disease in cystic fibrosis patients
R. Chiron, L. Crampette, I. Vachier, P. Godard, P. Chanez (Montpellier, France)
Source:
Annual Congress 2005 - From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session:
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session type:
Thematic Poster Session
Number:
732
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Chiron, L. Crampette, I. Vachier, P. Godard, P. Chanez (Montpellier, France). Relations between the sinonasal development and the lung disease in cystic fibrosis patients. Eur Respir J 2005; 26: Suppl. 49, 732
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Imaging of eosinophilic lung disease
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Early cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 77-87
Year: 2014
Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease
Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020
Year: 2021
Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014
Factors affecting progression of lung disease among patients with cystic fibrosis
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Improving airway clearance in cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 169-187
Year: 2014
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017
Year: 2018
Risk factors for lung disease progression in children with cystic fibrosis
Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018
Year: 2018
Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 528s
Year: 2002
Non invasive ventilation for advanced cystic fibrosis lung disease in children
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011
Lung function in children with cystic fibrosis liver disease
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021
How to diagnose cystic interstitial lung disease
Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Year: 2015
Elucidating progression of early cystic fibrosis lung disease
Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017
Year: 2017
The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2019; 83: 158-172
Year: 2019
Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Multiple cystic lung disease
Source: Eur Respir Rev 2015; 24: 552-564
Year: 2015
Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept